Prentice Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-251
Closed -$61K 211
2021
Q3
$61K Hold
251
0.03% 167
2021
Q2
$60K Hold
251
0.03% 170
2021
Q1
$55K Buy
+251
New +$50.4K 0.03% 168

Other funds holding LH

Prentice Wealth Management's LH Position: Q4 2021 in Review

Prentice Wealth Management sold out of Labcorp (LH) in Q4 2021, closing a stake of 251 shares — an estimated $61K sold.

Prentice Wealth Management first reported a position in LH in Q1 2021 and held it in 3 quarters. The position peaked at $61K in Q3 2021. 1,061 funds tracked by Wall St. Rank hold LH as of Q4 2021.

  • Prentice Wealth Management reported no remaining Labcorp position as of Q4 2021 after selling out during the quarter.
  • Prentice Wealth Management sold 251 Labcorp shares in Q4 2021, an estimated $61K.
  • Prentice Wealth Management first reported a position in Labcorp in Q1 2021 and held it in 3 quarters.
  • Prentice Wealth Management's Labcorp position peaked at $61K in Q3 2021.
  • 1,061 funds tracked by Wall St. Rank held Labcorp as of Q4 2021.

Based on Prentice Wealth Management's 13F filing for Q4 2021, filed 31 Oct 2022.